Teleflex (NYSE:TFX) Shares Gap Down – Here’s Why

Teleflex Incorporated (NYSE:TFX)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $126.53, but opened at $112.50. Teleflex shares last traded at $113.3870, with a volume of 720,314 shares traded.

Analyst Upgrades and Downgrades

TFX has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price objective on shares of Teleflex from $114.00 to $139.00 and gave the company an “equal weight” rating in a research report on Wednesday, December 10th. Royal Bank Of Canada restated a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a research note on Wednesday, December 17th. Zacks Research lowered shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Truist Financial increased their price target on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a report on Thursday, December 18th. Finally, Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. One research analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Teleflex currently has a consensus rating of “Reduce” and an average price target of $142.43.

Teleflex Stock Performance

The stock’s 50-day moving average price is $118.78 and its 200-day moving average price is $121.23. The company has a market capitalization of $4.86 billion, a price-to-earnings ratio of -15.04, a P/E/G ratio of 1.39 and a beta of 0.93. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The company’s revenue was up 19.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend was Friday, November 14th. Teleflex’s payout ratio is -18.50%.

Institutional Investors Weigh In On Teleflex

A number of large investors have recently added to or reduced their stakes in TFX. AQR Capital Management LLC raised its position in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after acquiring an additional 1,956,811 shares during the last quarter. Abrams Bison Investments LLC purchased a new position in shares of Teleflex during the 3rd quarter worth approximately $112,317,000. Norges Bank acquired a new position in shares of Teleflex during the 2nd quarter worth approximately $65,826,000. Thrivent Financial for Lutherans raised its position in shares of Teleflex by 1,161.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock worth $67,353,000 after purchasing an additional 506,796 shares during the last quarter. Finally, Capital International Investors purchased a new stake in Teleflex in the 3rd quarter valued at approximately $44,851,000. 95.62% of the stock is owned by institutional investors and hedge funds.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.